KS HB2695

Requires prescribers to provide FDA medication guides to parents or guardians before prescribing psychotropic drugs (stimulants, antidepressants, antipsychotics, and other behavioral drugs) to children under 18 receiving medical assistance (KanCare), and to obtain signed written informed consent acknowledging the risks, including black box warnings and pediatric-specific side effects.

Directs the Kansas Secretary of Health and Environment to develop and maintain a secure online reporting system where parents and caregivers can report adverse drug reactions to psychotropic drugs prescribed to children on medical assistance, including details on the drug, reaction type (physical, physiological, or behavioral), and severity level.

Requires quarterly reports to specified legislative committees beginning in the 2027 session summarizing adverse drug reaction data by age, severity, and reaction category, with information disaggregated by age, gender, and race but stripped of personally identifiable information.

Mandates annual reports to the same legislative committees on implementation efforts, compliance statistics, fiscal analysis, and health outcomes related to the act's provisions.

Classifies all individual-level data collected through the reporting system as confidential and exempt from the Kansas Open Records Act, with the confidentiality provision set to expire July 1, 2031, unless the legislature reenacts it.